This is a working overview of Melanotan II, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-05-30. Anything still debated is marked as such rather than presented as settled.
Pharmacologically, melanotan-2 behaves as a non-selective agonist across the melanocortin receptor family. Binding at MC1R on dermal melanocytes promotes eumelanin synthesis, which underlies the tanning response described in early human work. Activity at the centrally expressed MC4R receptor is associated with reported effects on appetite and erectile function. Because the peptide does not discriminate strongly among receptor subtypes, attributing any single observed effect to one receptor pathway is generally not possible without selective antagonists or receptor knockout models.
Research interest has centred on photoprotection and pigmentation, with a smaller body of work on appetite and sexual function. Published human data remain limited to small, frequently uncontrolled studies, and the compound has never received marketing approval from a national medicines regulator. Most laboratory work treats it as a pharmacological tool for probing melanocortin signalling in cell culture or animal models. Whether pigmentation changes observed in people translate into measurable protection against ultraviolet-induced DNA damage remains an open question.
Melanotan-2 is frequently confused with afamelanotide, a linear analogue authorised in the European Union for erythropoietic protoporphyria. The two compounds differ in chain length, ring structure and receptor selectivity, so findings for one cannot be transferred directly to the other. Published controlled human data on melanotan-2 remain sparse, and much of what circulates online derives from small studies or unpublished reports. Questions about effect size, dose-response behaviour and long-term safety therefore remain unresolved.
Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone. Its sequence incorporates a lactam bridge that constrains the peptide into a ring, which increases resistance to enzymatic breakdown relative to the natural hormone. Researchers at the University of Arizona synthesised the compound in the late 1980s and early 1990s while studying pigmentation pathways. It has never received marketing approval from any national medicines regulator. In the scientific literature it is usually described as a laboratory research reagent rather than a therapeutic product.
The peptide acts as a non-selective agonist at melanocortin receptors, showing affinity for MC1R, MC3R, MC4R and MC5R. Activation of MC1R on melanocytes drives the conversion of tyrosine into melanin and shifts production toward the darker eumelanin form. MC4R signalling in the central nervous system is linked to appetite and energy balance, which helps explain why reduced food intake appeared in early human studies. Effects on MC4R and on vascular tone also account for the erectile responses recorded as unexpected findings in those same trials.
| Property | Value | Notes |
|---|---|---|
| Common synonyms | Melanotan II; MT-II; N-acetyl-norleucyl-cyclo[Asp-His-D-Phe-Arg-Trp-Lys] amide | Naming follows peptide convention; the numeral distinguishes it from melanotan-1 |
| Molecular formula | C50H69N15O9 | Includes the lactam bridge; no counter-ion assumed |
| Monoisotopic mass | 1023.53 Da | Free base; salts and counter-ions shift the observed value |
| Appearance | White to off-white lyophilised powder | Batch-to-batch colour variation is not itself proof of impurity |
| Typical analytical method | RP-HPLC purity determination with ESI-MS identity confirmation | Retention time alone does not establish sequence identity |
The compound was developed in the late 1980s and 1990s by academic researchers investigating photoprotection. The rationale held that stimulating melanin production might reduce ultraviolet damage to skin and lower skin cancer risk. Early work examined receptor binding, pigment response, and short-term tolerability in small studies. That program did not produce an approved drug, and formal development stalled after early-phase trials. Whether induced pigmentation confers meaningful photoprotection remains an open question.
Outside regulated medicine, melanotan II circulates through online vendors as a research chemical, often marketed for tanning. Products sold this way vary widely in purity, concentration, and labeling accuracy, and independent testing has documented discrepancies. Published reports describe both pigment effects and adverse reactions, including nausea, flushing, and darkening of existing moles. Long-term safety data are sparse, and no large controlled trial has established a risk profile. Questions about cumulative effects on melanocytes remain unresolved in the literature.
Structurally, Melanotan-2 retains the core recognition motif of alpha-melanocyte-stimulating hormone while adding a lactam bridge that links two side chains and constrains the molecule into a ring. This modification lowers susceptibility to enzymatic degradation. The compound acts as an agonist at melanocortin receptors, particularly subtypes associated with melanin production. Because the same receptor family influences several physiological processes, researchers note that its activity is not confined to pigmentation alone. Receptor selectivity continues to be examined in published studies.
Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation signalling. Its sequence incorporates modified residues that increase potency and extend biological activity relative to the native hormone. The compound binds receptors of the melanocortin family and is examined mainly in laboratory research. It does not occur naturally and exists only as a manufactured chemical entity produced by solid-phase synthesis.
Bhattacharjee, S., Mukherjee, S., and Roy, S.* (2021) J Phys Chem B, 125, 5832-5837.https://doi.org/10.1021/acs.jpcb.1c03794 A peptide-based synthetic transcription factor selectively activates transcription in a mammalian cell. Roy, K., Mazumder, A., Ghosh, P., Naiya, G., Ghosh, B., & Roy, S.* (2018) Chem Commun. 54, 1611-1614.https://doi.org/10.1039/C7CC09279B A Peptide-based Synthetic Transcription Factor Selectively Down-regulates the Proto-oncogene CFOS in Tumour Cells and Inhibits Proliferation. Chakraborty, M. and Roy, S.* (2016) Chem Commun, 53, 376-379.https://doi.org/10.1039/C6CC08086C Specific Sequence of a Beta-turn in Human La Protein May Contribute to Species Specificity of Hepatitis C Virus. Kumar, A., Manna, AK., Ray, U., Mullick, R., Basu, G., Das, S., & Roy, S.* (2014) J Virol, 88, 4319-27. https://doi.org/10.1128/jvi.00049-14 A Synthetic Peptide Mimic of l-Cro shows Sequence-Specific Binding in vitro and in vivo. Mazumder, A., Maiti, A., Roy, K., & Roy, S.* (2012) ACS Chem Biol, 7, 1084-94. https://doi.org/10.1021/cb200523n Peptide-protein interactions suggest that acetylation of lysines 381 and 382 of p53 is important for positive coactivator 4/p53 interaction. Debnath, S., Chatterjee, S., Arif, M., Kundu, TK., & Roy, S.* (2011) J Biol Chem, 286, 25076-87.https://doi.org/10.1074/jbc.M110.205328 Differential recognition of phosphorylated transactivation domains of p53 by different p300 domains. Polley, S., Guha, S., Roy, NS., Kar, S., Sakaguch,i K., Chuman, Y., Swaminathan, V., Kundu, T., & Roy, S.* (2008) J Mol Biol, 376, 8-12.
Scarborough (; 2021 Census 623,610) is a district of Toronto, Ontario, Canada, situated in the eastern part of Toronto. Its borders are Victoria Park Avenue to the west, Steeles Avenue and the city of Markham to the north, Rouge River and the city of Pickering to the east, and Lake Ontario to the south. Scarborough was named after the English town of Scarborough, North Yorkshire, inspired by its cliffs. Scarborough is the site of several former Indigenous settlements dating back many centuries. It was settled by Europeans in the 1790s and has grown from a collection of small rural villages and farms to become a fully urbanized and diverse cultural community. Incorporated in 1850 as a township, the district became part of Metropolitan Toronto in 1953 and was reconstituted as a borough in 1967. The borough rapidly developed as a suburb of Toronto over the next decade and became a city in 1983. In 1998, the city and the rest of Metropolitan Toronto were amalgamated into the present city of Toronto. The Scarborough Civic Centre – the former city's last seat of government – now houses offices of the municipal government of Toronto. Since the end of the Second World War, the district has been a popular destination for new immigrants in Canada. As a result, it is one of the most diverse and multicultural areas in the Greater Toronto Area, being home to various religious groups and places of worship. It includes a number of natural landmarks, including the Toronto Zoo, Rouge Park, and the Scarborough Bluffs.
The Russification policies were harsh, and there were many repressions, particularly in the aftermath of the November Uprising (1830–1831) and later, the January Uprising of 1863–1864. Many Poles were exiled to Siberia, some 80,000 of them in 1864 in the single largest deportation action commenced by the empire. Polish language was discriminated against, and it lost its official status. "Books were burned; churches destroyed; priests murdered;" wrote Norman Davies. There was no education in the Polish language, and publications in Polish were few. The only elementary schools were constantly underfinanced. The city of Warsaw under the Tsarist rule resembled a military base with exclusively Russian stores and clubs as well as 12 Russian garrisons in the city, equipped with newly built horse stables, and amenities like laundry shacks, and cabbage pickleries. Polish stores – where Russian was not being spoken – were routinely denied a license. Polish names were removed even from botanical signs. Hunger and poverty were rampant with record number of women forced to work at the Russian military brothels, of which there were some 185 in total, including 16 official ones (1884). In cheap army brothels, sex could be bought for as little as 30 kopecks (less than 1/3 of a rouble); one woman for every 30 Russians stationed at a garrison, with beatings and instances of women getting killed by them in drunken rages. Sex slaves were obliged to drink with the clients as a general rule.
=== Cell death === A cancer cell can die in three ways: apoptosis, necrosis, and autophagy. Excessive ROS can induce apoptosis through both the extrinsic and intrinsic pathways. In the extrinsic pathway of apoptosis, ROS are generated by Fas ligand as an upstream event for Fas activation via phosphorylation, which is necessary for subsequent recruitment of Fas-associated protein with death domain and caspase 8 as well as apoptosis induction. In the intrinsic pathway, ROS function to facilitate cytochrome c release by activating pore-stabilizing proteins (Bcl-2 and Bcl-xL) as well as inhibiting pore-destabilizing proteins (Bcl-2-associated X protein, Bcl-2 homologous antagonist/killer). The intrinsic pathway is also known as the caspase cascade and is induced through mitochondrial damage which triggers the release of cytochrome c. DNA damage, oxidative stress, and loss of mitochondrial membrane potential lead to the release of the pro-apoptotic proteins mentioned above stimulating apoptosis. Mitochondrial damage is closely linked to apoptosis and since mitochondria are easily targeted there is potential for cancer therapy. The cytotoxic nature of ROS is a driving force behind apoptosis, but in even higher amounts, ROS can result in both apoptosis and necrosis, a form of uncontrolled cell death, in cancer cells. Numerous studies have shown the pathways and associations between ROS levels and apoptosis, but a newer line of study has connected ROS levels and autophagy.
Prenatal cocaine exposure (PCE) may occur when a pregnant woman uses cocaine. Under the former FDA pregnancy category system, cocaine was classified as a Category C drug. Its potential to cause harm to the fetus is not fully known, so it should only be administered to pregnant women if clearly necessary. Cocaine can act as a teratogen, having various effects on the developing fetus. Some common teratogenic defects caused by cocaine include hydronephrosis, cleft palate, polydactyly, and down syndrome. Cocaine as a drug has a low molecular weight and high water and lipid solubility which enables it to cross the placenta and fetal blood-brain barrier. Because cocaine is able to pass through the placenta and enter the fetus, the fetus' circulation can be negatively affected. With restriction of fetal circulation, the development of organs in the fetus can be impacted, even resulting in intestines developing outside of the fetus' body. Cocaine use during pregnancy can also result in obstetric labor complications such as, placental abruption, preterm birth or delivery, uterine rupture, miscarriage, and stillbirth. Prenatal cocaine exposure may cause subtle cognitive deficits and lower the chance of above-average IQ by age 4, but supportive caregiving can significantly improve outcomes.
Sources: en.wikipedia.org
== Desorption mass spectrometry matrix == In mass spectrometry this compound is often abbreviated as "3-NBA" or "m-NBA." It has been used as a liquid matrix for fast atom bombardment and matrix-assisted laser desorption ionization. In electrospray ionization 3-NBA is doped into low surface tension spray solvents to increase analyte charging.
=== Legal status === The FDA granted the application for pegcetacoplan orphan drug designation. In October 2021, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion, recommending the granting of a marketing authorization for the medicinal product Aspaveli, intended for the treatment of adults with paroxysmal nocturnal hemoglobinuria. The applicant for this medicinal product is Swedish Orphan Biovitrum AB (publ). Pegcetacoplan was approved for the treatment of paroxysmal nocturnal hemoglobinuria in the European Union in December 2021. FDA approved Syfovre for the treatment of geographic atrophy secondary to age-related macular degeneration (ARMD) in February 2023. In June 2024, the CHMP recommended the refusal of a marketing authorization for Syfovre, a medicine intended for the treatment of geographic atrophy caused by age-related macular degeneration. The manufacturer requested a re-examination in July 2024. In September 2024, the CHMP continued to refuse a marketing authorization after a re-examination.
Moreover, Esimone's research team was the first to demonstrate the occurrence of the FOX-1 gene, responsible for expressing the AmpC enzyme in gram-negative bacteria in Nigeria. This enzyme significantly enhances the ability of organisms to resist cephamycin antibiotics.
=== Fluorescent detection === Fluorescence spectroscopy is one of the most common droplet detection techniques. It provides a rapid response, and, for applicable analytes, it has a strong signal. The use of fluorescence spectroscopy in microfluidics follows a similar format to most other fluorescent analytical techniques. A light source is used to excite analyte molecules in the sample, after which the analyte fluoresces, and the fluorescence response is the measured output. Cameras can be used to capture the fluorescence signal of the droplets, and filters are often used to filter out scattered excitation light. In microfluidic droplet detection, the experimental setup of a fluorescence instrument can vary greatly. A common setup in fluorescent droplet detection is with the use of an epifluorescence microscope. This sometimes utilizes a confocal geometry, which can vary depending on experimental needs. For example, Jeffries et al. reported success with exploring an orthogonal confocal geometry, as opposed to a standard epi geometry. However, other setups for fluorescence detection have been explored, as epifluorescence microscopes can be expensive and difficult to upkeep. Cole et al. have proposed and tested an experimental setup with fiber optics to conduct fluorescence analysis of microfluidic droplets. Fluorescence detection of droplets has a number of advantages. First, it can accommodate a large and fast throughput. Analysis of thousands of samples can be conducted in a short period of time, which is advantageous for the analysis of a large number of samples.
Sources: en.wikipedia.org
It is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone, containing seven amino acids with a lactam ring and a D-configured phenylalanine residue. It is supplied as a lyophilised powder for laboratory research.
The natural hormone is a linear tridecapeptide that is rapidly degraded in circulation. Melanotan-2 is shortened, cyclised, N-terminally acetylated, and carries a D-amino acid substitution, all of which slow enzymatic breakdown.
No national medicines regulator has approved melanotan-2 for therapeutic or cosmetic use. In several jurisdictions it is treated as an unapproved prescription medicine, and its legal classification differs from country to country.
It is a synthetic cyclic heptapeptide modelled on alpha-melanocyte-stimulating hormone. A lactam bridge links two side chains, forming a ring that stabilises the molecule against proteolysis. It belongs to the broader melanocortin peptide family.